<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) has been implicated in the pathogenesis of a variety of <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> (LPDs) including endemic Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>), HIV-associated non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHLs), and LPDs arising in immunosuppressed transplant patients </plain></SENT>
<SENT sid="1" pm="."><plain>More recently, EBV has been associated with Ki-1-positive anaplastic large cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e>), a recently described NHL that shares with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> expression of the CD30 antigen Ki-1 </plain></SENT>
<SENT sid="2" pm="."><plain>Because EBV has been shown to induce Ki-1 expression in vitro, and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e> has been diagnosed in patients with prior or concurrent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> or NHL, it has been proposed that EBV may mediate progression of a "primary" <z:hpo ids='HP_0002665'>lymphoma</z:hpo> to a "secondary" <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We report a case in which an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>-associated, Ki-1-negative, large-cell <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphoma</z:hpo> progressed to a Ki-1 positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Analysis of the immunoglobulin heavy chain locus revealed a clonal relationship between these morphologically and immunophenotypically distinct <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Although EBV was absent from the original large-cell <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphoma</z:hpo> as assessed by in situ hybridization for EBV-encoded small RNA1 (EBER1), polymerase chain reaction for EBNA-1, immunocytochemistry for latent membrane protein 1, and Southern blot hybridization for EBV terminal repeat sequences, <z:hpo ids='HP_0000001'>all</z:hpo> for techniques confirmed the presence of EBV in the secondary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, analysis of EBV terminal repeat sequences indicated that the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e> resulted from expansion of a single EBV-infected clone </plain></SENT>
<SENT sid="7" pm="."><plain>These data suggest that EBV may mediate progression of NHL to Ki-1-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ALCL</z:e>, and that in some instances, EBV may be involved in the later stages of clonal progression of NHL </plain></SENT>
</text></document>